'Targeted & immunotherapy combination has demonstrated improved survival in RCC' https://ift.tt/0WtpNTc

World Kidney Cancer Day: Renal cell carcinoma (RCC) is generally resistant to traditional chemotherapy and radiation therapy. It is crucial that patients with advanced or metastatic kidney cancer receive systemic therapy that includes targeted therapy and immunotherapy.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/nZlHkmD
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.